facebook linkedin twitter

Prescription Drugs

2021-07-23 20:15:27
by Tom Ramstack
Opioid Maker and Distributors Settle State Lawsuits for $26 Billion

A coalition of state attorneys general reached a $26 billion settlement with opioid maker Johnson & Johnson and three of... Read More

A coalition of state attorneys general reached a $26 billion settlement with opioid maker Johnson & Johnson and three of its distributors this week. They blame the companies for a half-million deaths in the United States from overdoses and addictions... Read More

Pfizer to Discuss Vaccine Booster with US Officials Monday

WASHINGTON (AP) — Pfizer says it plans to meet with top U.S. health officials Monday to discuss the drugmaker's request... Read More

WASHINGTON (AP) — Pfizer says it plans to meet with top U.S. health officials Monday to discuss the drugmaker's request for federal authorization of a third dose of its COVID-19 vaccine as President Joe Biden's chief medical adviser acknowledged that... Read More

2021-07-09 13:16:39
by Dan McCue
Both Sides Lay Cards on The Table on Drug Pricing

WASHINGTON - A trio of House Democrats, including House Speaker Nancy Pelosi, D-Calif., and Rep. Carolyn Maloney, D-N.Y., chair of... Read More

WASHINGTON - A trio of House Democrats, including House Speaker Nancy Pelosi, D-Calif., and Rep. Carolyn Maloney, D-N.Y., chair of the House Committee on Oversight and Reform, accused the nation’s largest pharmaceutical companies on Thursday of being more concerned with... Read More

2021-07-08 17:38:20
by Dan McCue
FDA Changes Prescribing Instructions for Controversial Alzheimer’s Drug

U.S. health regulators on Thursday approved new prescribing instructions that are likely to limit use of a controversial new Alzheimer’s... Read More

U.S. health regulators on Thursday approved new prescribing instructions that are likely to limit use of a controversial new Alzheimer’s drug. The announcement came through Biogen Inc., the maker of Aduhelm, which stated the update is intended to “clarify” the... Read More

More States Agree to Settlement Plan for Opioid-maker Purdue

More than a dozen states have dropped their longstanding objections to OxyContin maker Purdue Pharma's reorganization plan, edging the company... Read More

More than a dozen states have dropped their longstanding objections to OxyContin maker Purdue Pharma's reorganization plan, edging the company closer to resolving its bankruptcy case and transforming itself into a new entity that helps combat the U.S. opioid epidemic... Read More

2021-06-30 14:31:12
by Alexa Hornbeck
Health Summit Panel Debates Drug Pricing Proposals

Policymakers and representatives of the pharmaceutical industry debated the cost of prescription drugs and the myriad of proposals on Capitol... Read More

Policymakers and representatives of the pharmaceutical industry debated the cost of prescription drugs and the myriad of proposals on Capitol Hill to bring those prices down at last week's Milken Institute Future of Health Summit. Amitabh Chandra, a health care... Read More

Democrats Seek Narrow Path to Rein in Cost of Medicines

WASHINGTON (AP) — President Joe Biden's call for authorizing Medicare to negotiate lower prescription drug prices has energized Democrats on... Read More

WASHINGTON (AP) — President Joe Biden's call for authorizing Medicare to negotiate lower prescription drug prices has energized Democrats on a politically popular idea they've been pushing for nearly 20 years only to encounter frustration. But they still lack a... Read More

2021-04-19 14:18:13
by Tom Ramstack
Pharmaceutical Executives Suggest Annual COVID-19 Vaccinations

Officials from the top U.S. pharmaceutical companies making the COVID-19 vaccine are saying vaccinated persons are likely to need booster... Read More

Officials from the top U.S. pharmaceutical companies making the COVID-19 vaccine are saying vaccinated persons are likely to need booster shots within a year. In fact, they probably will need to get vaccinated yearly for the foreseeable future, similar to... Read More

2021-03-10 14:33:10
by Tom Ramstack
Alarming Lapses in Inspection of Drugs Made in Foreign Countries

WASHINGTON -- A government report released Tuesday raised alarms about the quality of pharmaceuticals made in foreign countries but consumed... Read More

WASHINGTON -- A government report released Tuesday raised alarms about the quality of pharmaceuticals made in foreign countries but consumed by Americans. It said the purity of the drugs is questionable because of a lack of adequate inspections by the... Read More

2020-12-18 16:01:29
by Tom Ramstack
Lawmakers Lay Blame for Opioid Epidemic on Purdue Pharma

WASHINGTON -- Members of Congress lashed into the Sackler family Thursday for its pharmaceutical company’s role in promoting a painkiller... Read More

WASHINGTON -- Members of Congress lashed into the Sackler family Thursday for its pharmaceutical company’s role in promoting a painkiller blamed for killing about 230,000 Americans. Lawmakers on the House Oversight and Reform Committee said the Sacklers and Purdue Pharma... Read More

Amid Hope for Pfizer Vaccine, States Grapple with Distribution

A COVID-19 vaccine from Pfizer Inc. may be on the horizon, but the cost of distributing vaccines across all 50 states and... Read More

A COVID-19 vaccine from Pfizer Inc. may be on the horizon, but the cost of distributing vaccines across all 50 states and who will pay for that operation remains a huge stumbling block. What is clear is that much of the financial... Read More

2020-11-09 21:30:37
by Dan McCue
Pfizer Says COVID-19 Vaccine Appears to be 90% Effective

Stocks surged around the world Monday after Pfizer announced that early results from trials of its coronavirus vaccine suggest the... Read More

Stocks surged around the world Monday after Pfizer announced that early results from trials of its coronavirus vaccine suggest the shots may be 90% effective at preventing COVID-19. But President-elect Joe Biden quickly reminded Americans that the good news does... Read More

Biden Advisers Met With Warp Speed Drugmakers Before Election

President-elect Joe Biden's health care advisers have held talks with pharmaceutical-industry executives in which they discussed Operation Warp Speed, the U.S. development program for... Read More

President-elect Joe Biden's health care advisers have held talks with pharmaceutical-industry executives in which they discussed Operation Warp Speed, the U.S. development program for coronavirus vaccines and treatments, according to people familiar with the matter. Biden advisers met with companies that have COVID-19 vaccines... Read More

Supreme Court Hears Drug Benefits Case with Wide-Ranging Impact

WASHINGTON — The Supreme Court heard arguments Tuesday on state regulation of prescription drug benefit companies in a case with... Read More

WASHINGTON — The Supreme Court heard arguments Tuesday on state regulation of prescription drug benefit companies in a case with potential impacts for health care across most of the country. Rutledge v. Pharmaceutical Care Management Association addresses a 2015 Arkansas... Read More

Pharma Lobby Disputes Trump’s Claim That Drug Companies Are Negotiating

WASHINGTON — The pharmaceutical industry’s leading lobby group said Tuesday it did not know of a meeting at the White... Read More

WASHINGTON — The pharmaceutical industry’s leading lobby group said Tuesday it did not know of a meeting at the White House to discuss lowering prescription drug prices, after President Donald Trump said executives were coming in this week to negotiate.... Read More

2020-08-06 17:45:14
by Dan McCue
Trump to Require Government to Buy American When It Comes to 'Essential' Drugs

WASHINGTON - President Donald Trump signed an executive order Thursday requiring the federal government to buy "essential" drugs from U.S.... Read More

WASHINGTON - President Donald Trump signed an executive order Thursday requiring the federal government to buy "essential" drugs from U.S. companies, a White House trade advisor said. “If we’ve learned anything from the China virus pandemic, it is that we... Read More

2020-07-24 23:26:22
by Dan McCue
Slipping in Polls, President Banks All on Hastily Assembled Pharma Policy

WASHINGTON - President Donald Trump signed four executive orders Friday afternoon that he says will dramatically reduce the cost of... Read More

WASHINGTON - President Donald Trump signed four executive orders Friday afternoon that he says will dramatically reduce the cost of prescription drugs. But even before his press conference in the Old Executive Office building was over, the orders were being... Read More

2020-03-19 20:51:52
by Dan McCue
Schrader's Bipartisan Approach to Legislating Reaps Benefits on Drug Pricing, Education

WASHINGTON - Rep. Kurt Schrader doesn't miss a chance to reach across the aisle if it will benefit his constituents.... Read More

WASHINGTON - Rep. Kurt Schrader doesn't miss a chance to reach across the aisle if it will benefit his constituents. Among the most recent of multiple examples is the Oregon representative’s introduction of H.R. 4455, the Bolstering Innovative Options to... Read More

Georgia City Sues Drug Company Over Medicine That Went from $40 to $39,000

ATLANTA — The city of Marietta, Ga., has filed a class action lawsuit against a drug company after the price... Read More

ATLANTA — The city of Marietta, Ga., has filed a class action lawsuit against a drug company after the price of a decades-old medicine went from $40 a vial to more than $39,000. The city, which covers health care costs... Read More

2020-01-31 13:15:30
by Tom Ramstack
Congress Weighs Options to Control Opioid Copycats

WASHINGTON -- Drug control experts urged Congress Tuesday to take quick action to prevent drugs created by clandestine chemists that... Read More

WASHINGTON -- Drug control experts urged Congress Tuesday to take quick action to prevent drugs created by clandestine chemists that mimic the effects of opioids from entering legal and illegal marketplaces. They suggested that Congress turn a temporary order on... Read More

Congress Seeks Drug-Pricing Deal in Spite of 2020 Rancor

WASHINGTON — In an election year when nobody expects Congress to pass meaningful legislation, lawmakers are feeling strong political pressure... Read More

WASHINGTON — In an election year when nobody expects Congress to pass meaningful legislation, lawmakers are feeling strong political pressure to reach a deal on at least one main voter priority: lowering drug prices. The most likely result could be... Read More

2019-12-12 15:32:48
by Dan McCue
Horn Seeking to Address Prescription Drug Prices in ‘Smart and Effective’ Ways

WASHINGTON - Rep. Kendra Horn believes it should come as no surprise to anyone that reining in runaway prescription drug... Read More

WASHINGTON - Rep. Kendra Horn believes it should come as no surprise to anyone that reining in runaway prescription drug prices has been a top priority of members of the 116th Congress. "After all, they are something that impacts just... Read More

2019-12-04 22:50:47
by Dan McCue
Cunningham Hit Ground Running When It Came To Tamping Down on Drug Prices

WASHINGTON - In the Lowcountry of South Carolina, Rep. Joe Cunningham's race for Congress quickly became the stuff of local... Read More

WASHINGTON - In the Lowcountry of South Carolina, Rep. Joe Cunningham's race for Congress quickly became the stuff of local legend. Here was a first-time candidate, a Democrat running in a staunchly Republican district, who defeated a well-financed GOP opponent,... Read More

2019-12-04 22:48:49
by Dan McCue
Brindisi Working to Rein in High Prescription Drug Prices

WASHINGTON - Rep. Anthony Brindisi, D-N.Y., knows the stories all too well. Time and again during town halls and community... Read More

WASHINGTON - Rep. Anthony Brindisi, D-N.Y., knows the stories all too well. Time and again during town halls and community events in his district, he's heard the first-hand stories of hardworking families who've had to choose between paying for a... Read More

2019-12-04 22:42:26
by Dan McCue
Murphy Leads Effort to Revive Bipartisan Addiction Treatment Bill

WASHINGTON - Rep. Stephanie Murphy, D-Fla., joined with Reps. Brian Fitzpatrick, R-Pa., and Annie Kuster, D-N.H., to re-introduce the Road... Read More

WASHINGTON - Rep. Stephanie Murphy, D-Fla., joined with Reps. Brian Fitzpatrick, R-Pa., and Annie Kuster, D-N.H., to re-introduce the Road to Recovery Act, a bill that would improve addiction treatment options under Medicaid and the Children’s Health Insurance Program. Specifically,... Read More

2019-12-04 22:39:15
by Dan McCue
Rep. McAdams Backs Legislation to Speed Generic Medications to Market

WASHINGTON - While some continue to merely talk about the need to rein in prescription drug prices, Rep. Ben McAdams,... Read More

WASHINGTON - While some continue to merely talk about the need to rein in prescription drug prices, Rep. Ben McAdams, D-Utah, has actually taken action on bipartisan legislation to help lower the cost of often life-changing medications. Along with fellow... Read More

2019-11-08 21:18:01
by Dan McCue
Peters Helps Advance Bill to Lower Prescription Drug Prices From Committee

WASHINGTON - Rep. Scott Peters, D-Calif., helped advance H.R. 3, the Lower Drug Costs Now Act, joining the majority of... Read More

WASHINGTON - Rep. Scott Peters, D-Calif., helped advance H.R. 3, the Lower Drug Costs Now Act, joining the majority of his colleagues on the Energy and Commerce Committee in voting to send the measure on to the full House. The... Read More

2019-10-22 13:07:09
by Dan McCue
Rose Hosts District Roundtable on Prescription Drug Prices

WASHINGTON - Rep. Max Rose hosted a roundtable for seniors in Brooklyn, N.Y. on Saturday to bring them up to... Read More

WASHINGTON - Rep. Max Rose hosted a roundtable for seniors in Brooklyn, N.Y. on Saturday to bring them up to speed on his proposal to lower prescription drug prices. Rose met with members of AARP Bay Ridge Chapter 3630 to... Read More

2019-10-08 22:57:26
by Dan McCue
Blue Dogs Call on Congress to Take Up Additional Bipartisan Drug Pricing Legislation

WASHINGTON—As the House continues its consideration of H.R. 3, Lower Drug Costs Now Act of 2019, the Blue Dog Coalition... Read More

WASHINGTON—As the House continues its consideration of H.R. 3, Lower Drug Costs Now Act of 2019, the Blue Dog Coalition has endorsed and called on Congress to take up a series of additional prescription drug pricing bills that, if taken... Read More

2019-08-27 20:46:49
by Dan McCue
Grassley Anticipates Bipartisan Push to Lower Prescription Drug Prices

WASHINGTON - Senate Finance Chairman Chuck Grassley, R- Iowa, is expected to mount a full-court, bipartisan press to see that... Read More

WASHINGTON - Senate Finance Chairman Chuck Grassley, R- Iowa, is expected to mount a full-court, bipartisan press to see that legislation lowering prescription drug prices is passed before the end of the year. Chairman Grassley recently met with Senate Health... Read More

1 2
Straight From The Well
scroll top